1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Oral Mucositis Global Clinical Trials Review, H1, 2014

Oral Mucositis Global Clinical Trials Review, H1, 2014

  • April 2014
  • -
  • Global Data
  • -
  • 88 pages

Oral Mucositis Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Oral Mucositis Global Clinical Trials Review, H1, 2014" provides data on the Oral Mucositis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oral Mucositis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oral Mucositis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Oral Mucositis Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Oral Mucositis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Oral Mucositis to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Oral Mucositis to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Oral Mucositis 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Oral Mucositis Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Oral Mucositis 33
Dec 05, 2013: Soligenix Announces Initiation of a Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 33
Jun 10, 2013: BioAlliance Pharma Initiates Phase II Clinical Trial With Validive In US 33
Feb 14, 2013: BioAlliance Pharma Announces Forthcoming Extension Of Its Phase II Clinical Trial With Validive In US 34
Oct 29, 2012: Doxepin Rinse Reduces Mouth Pain For Head And Neck Cancer Patients Who Receive Radiation Therapy, Study Finds 34
Aug 22, 2012: ActoGeniX Announces Positive Results From Phase I Study Of AG013 For Prevention Of Oral Mucositis In Cancer Patients 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Amgen Inc. 36
Clinical Trial Overview of Amgen Inc. 36
Swedish Orphan Biovitrum AB 38
Clinical Trial Overview of Swedish Orphan Biovitrum AB 38
Soligenix, Inc. 39
Clinical Trial Overview of Soligenix, Inc. 39
Cellceutix Corporation 40
Clinical Trial Overview of Cellceutix Corporation 40
Jazz Pharmaceuticals plc 41
Clinical Trial Overview of Jazz Pharmaceuticals plc 41
Endo International plc 42
Clinical Trial Overview of Endo International plc 42
Daewoong Co., Ltd. 43
Clinical Trial Overview of Daewoong Co., Ltd. 43
CD Pharma India Private Ltd. 44
Clinical Trial Overview of CD Pharma India Private Ltd. 44
Biotec Pharmacon ASA 45
Clinical Trial Overview of Biotec Pharmacon ASA 45
ActogeniX NV 46
Clinical Trial Overview of ActogeniX NV 46
Clinical Trial Overview of Top Institutes / Government 47
The University of Texas M. D. Anderson Cancer Center 47
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 47
Children's Oncology Group 48
Clinical Trial Overview of Children's Oncology Group 48
Hadassah Medical Organization 49
Clinical Trial Overview of Hadassah Medical Organization 49
University Hospital Freiburg 50
Clinical Trial Overview of University Hospital Freiburg 50
Radiation Therapy Oncology Group 51
Clinical Trial Overview of Radiation Therapy Oncology Group 51
North Central Cancer Treatment Group 52
Clinical Trial Overview of North Central Cancer Treatment Group 52
All India Institute of Medical Sciences 53
Clinical Trial Overview of All India Institute of Medical Sciences 53
The University of Texas Health Science Center at San Antonio 54
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 54
Shahid Beheshti University 55
Clinical Trial Overview of Shahid Beheshti University 55
UCLA's Jonsson Comprehensive Cancer Center 56
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 56
Five Key Clinical Profiles 57
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 88

List of Tables
Oral Mucositis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Oral Mucositis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Oral Mucositis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Oral Mucositis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Oral Mucositis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Oral Mucositis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Oral Mucositis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Oral Mucositis to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Oral Mucositis to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Oral Mucositis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Oral Mucositis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Oral Mucositis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Oral Mucositis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Oral Mucositis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Oral Mucositis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Oral Mucositis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Oral Mucositis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Oral Mucositis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Oral Mucositis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Oral Mucositis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 36
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Swedish Orphan Biovitrum AB, 2014* 38
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Soligenix, Inc., 2014* 39
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cellceutix Corporation, 2014* 40
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jazz Pharmaceuticals plc, 2014* 41
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014* 42
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daewoong Co., Ltd., 2014* 43
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by CD Pharma India Private Ltd., 2014* 44
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotec Pharmacon ASA, 2014* 45
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by ActogeniX NV, 2014* 46
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 47
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 48
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 49
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2014* 50
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 51
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014* 52
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 53
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2014* 54
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2014* 55
Oral Mucositis Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014* 56

List of Figures
Oral Mucositis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Oral Mucositis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Oral Mucositis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Oral Mucositis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Oral Mucositis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Oral Mucositis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Oral Mucositis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Oral Mucositis to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Oral Mucositis to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Oral Mucositis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Oral Mucositis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Oral Mucositis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Oral Mucositis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Oral Mucositis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Oral Mucositis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Oral Mucositis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Oral Mucositis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

  • $ 5274
  • Industry report
  • September 2016
  • by Industry ARC

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.